SLGL
SLGL
NASDAQ · Pharmaceuticals

Sol-Gel Technologies Ltd

$87.82
+21.62 (+32.66%)
As of Mar 24, 4:10 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target -85.9% upside
Low Target $7.31
Average Target $12.40
High Target $17.49
Current Price $87.82
Current
$87.82
Target
$12.40
$7.31 $12.40 avg $17.49
Scenario Analysis
Bear Case
$7.31
-91.7%
Low target
Base Case
$12.40
-85.9%
Avg target
Bull Case
$17.49
+-80.1%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$97.97
-10.4% from high
52-Week Low
$4.02
+2,084.6% from low
Target vs 52W High
$12.40
-87.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%